Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy

Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Gynecologic Oncology Unpaywall

Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy

Gynecologic OncologyMay 1, 2015

Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy

Gynecologic OncologyMay 1, 2015

Loading next page...
 
/lp/unpaywall/two-decades-beyond-brca1-2-homologous-recombination-hereditary-cancer-IXQU5s0NxV

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0090-8258
DOI
10.1016/j.ygyno.2015.02.017
Publisher site
See Article on Publisher Site

Abstract

Journal

Gynecologic OncologyUnpaywall

Published: May 1, 2015

There are no references for this article.